{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The BREAST trial was a randomized clinical trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The BREAST trial was a randomized clinical trial conducted between November 2, 2015, and October 31, 2021, performed in 7 hospitals across the Netherlands."
      },
      "Participants": {
        "score": 2,
        "evidence": "The patients with breast cancer who had undergone mastectomy and were seeking breast reconstruction were screened for eligibility (radiotherapy history and physique) by participating plastic surgeons."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Interventions: Breast reconstruction with AFT plus expansion or 2-phased IBR."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To investigate quality of life (QoL) among patients undergoing a new breast reconstruction technique, autologous fat transfer (AFT), compared with that among patients undergoing implant-based reconstruction (IBR)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The predefined primary outcome was QoL at 12 months after final surgery."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomization was done in a 1:1 ratio."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 193 female patients (mean [SD] age, 49.2 [10.6] years) 18 years or older who desired breast reconstruction were included."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "In total, 64 women in the AFT group and 68 women in the IBR group completed follow-up."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The BREAST-Q scores were higher in the AFT group in all 5 domains and significantly higher in 3: satisfaction with breasts (difference, 9.9; P =\u2009.002), physical well-being: chest (difference; 7.6; P =\u2009.007), and satisfaction with outcome (difference, 7.6; P =\u2009.04)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No differences in oncological serious adverse events were found."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial Registration: ClinicalTrials.gov Identifier: NCT02339779"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}